Yatharth Hospital & Trauma Care Services Ltd is Rated Hold

1 hour ago
share
Share Via
Yatharth Hospital & Trauma Care Services Ltd is rated 'Hold' by MarketsMojo, with this rating last updated on 03 August 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 22 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Yatharth Hospital & Trauma Care Services Ltd is Rated Hold

Understanding the Current Rating

The 'Hold' rating assigned to Yatharth Hospital & Trauma Care Services Ltd indicates a neutral stance for investors. It suggests that while the stock is not an immediate buy, it also does not warrant a sell recommendation at this time. This rating is based on a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Each of these factors contributes to the overall assessment of the stock’s investment potential.

Quality Assessment

As of 22 September 2026, the company’s quality grade is considered average. This is reflected in its return on equity (ROE), which stands at 9.01%. While this indicates the company is generating profits from shareholders’ funds, the level of profitability per unit of equity is modest compared to industry leaders. The company has demonstrated consistent operational performance, declaring positive results for the last 12 consecutive quarters, signalling stability in earnings. However, the relatively low ROE suggests room for improvement in management efficiency and profitability.

Valuation Perspective

Currently, Yatharth Hospital & Trauma Care Services Ltd is classified as very expensive in terms of valuation. The stock trades at a price-to-book (P/B) ratio of 6.1, which is significantly higher than the average valuations of its peers in the hospital sector. This premium valuation reflects investor optimism but also implies that the stock price already incorporates expectations of strong future growth. The price-earnings-to-growth (PEG) ratio of 2.2 further indicates that the stock is priced above its earnings growth rate, suggesting cautious consideration for value-focused investors.

Financial Trend and Performance

The financial trend for Yatharth Hospital & Trauma Care Services Ltd is positive. The company reported a profit after tax (PAT) of ₹139.93 crores for the nine months ended, growing at a robust rate of 25.78%. Quarterly earnings before depreciation, interest, and taxes (PBDIT) reached a high of ₹91.68 crores, underscoring operational strength. Additionally, the debtors turnover ratio of 3.20 times indicates efficient management of receivables. Importantly, the company is net-debt free, which reduces financial risk and provides flexibility for future investments or expansion.

Technical Analysis

From a technical standpoint, the stock exhibits a bullish trend. Recent price movements show strong momentum, with returns of +30.90% over the past month and +74.49% over six months as of 22 September 2026. Year-to-date returns stand at +64.11%, and the stock has delivered +44.46% over the last year. Despite a minor dip of -0.42% on the most recent trading day, the overall technical indicators suggest sustained investor interest and positive market sentiment.

Investor Considerations

While the stock’s performance and financial health are encouraging, investors should be mindful of certain risks. Institutional investor participation has declined slightly, with a reduction of 0.79% in their holdings over the previous quarter, now standing at 16.47%. Institutional investors typically possess greater analytical resources, and their reduced stake may signal caution. Furthermore, the premium valuation demands that the company continues to deliver strong earnings growth to justify its current price levels.

Summary for Investors

The 'Hold' rating for Yatharth Hospital & Trauma Care Services Ltd reflects a balanced view. The company demonstrates solid financial trends and technical strength, supported by consistent profitability and a net-debt-free balance sheet. However, the average quality grade and very expensive valuation suggest that investors should monitor the stock closely for any changes in fundamentals or market conditions. For those already holding the stock, maintaining the position while observing upcoming quarterly results and market developments may be prudent. Prospective investors might consider waiting for a more attractive valuation or clearer signs of improved profitability before initiating new positions.

Our latest monthly pick, this Large Cap from Aluminium & Aluminium Products, is outperforming the market! See the analysis that helped our Investment Committee select this winner.

  • - Market-beating performance
  • - Committee-backed winner
  • - Aluminium & Aluminium Products standout

Read the Winning Analysis →

Company Profile and Market Capitalisation

Yatharth Hospital & Trauma Care Services Ltd operates within the hospital sector and is classified as a small-cap company. Its market capitalisation reflects its size relative to larger healthcare providers, which can influence liquidity and volatility. The hospital sector remains a critical component of the healthcare industry, with demand driven by demographic trends and increasing healthcare awareness. The company’s position within this sector and its operational metrics provide context for its current rating and investment appeal.

Stock Returns and Market Performance

The stock’s recent performance has been notable. As of 22 September 2026, it has delivered a one-week return of +13.75%, a one-month return of +30.90%, and a three-month return of +31.22%. Over six months, the stock surged by +74.49%, while year-to-date gains stand at +64.11%. These figures highlight strong momentum and investor confidence in the company’s prospects. The one-year return of +44.46% further confirms sustained appreciation, although investors should weigh these gains against valuation concerns and sector dynamics.

Management Efficiency and Profitability

Despite positive earnings growth, the company’s management efficiency, as measured by ROE, remains modest at 9.01%. This suggests that while the company is profitable, it is not maximising returns on shareholders’ equity to the fullest extent. Improving operational efficiency and profitability metrics could enhance investor confidence and potentially lead to a more favourable rating in the future.

Debt and Financial Stability

One of the company’s strengths is its net-debt-free status, which reduces financial risk and interest burden. This financial stability provides a solid foundation for future growth initiatives and shields the company from adverse credit market conditions. The strong debtors turnover ratio of 3.20 times also indicates effective management of receivables, contributing positively to cash flow and working capital management.

Institutional Investor Activity

Institutional investors currently hold 16.47% of the company’s shares, but their stake has decreased by 0.79% over the previous quarter. This decline may reflect a cautious stance or portfolio rebalancing. Given that institutional investors often have superior analytical capabilities, their reduced participation warrants attention from retail investors, who should consider this factor alongside other fundamental and technical indicators.

Conclusion

In summary, Yatharth Hospital & Trauma Care Services Ltd’s 'Hold' rating by MarketsMOJO reflects a nuanced view of the company’s current standing. The stock exhibits strong recent returns and positive financial trends, supported by a net-debt-free balance sheet and consistent profitability. However, the premium valuation and average quality metrics suggest that investors should approach with measured expectations. Monitoring future earnings reports, management efficiency improvements, and institutional investor activity will be key to reassessing the stock’s outlook.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News